These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17663974)

  • 1. [A new case: pioglitazone hepatotoxicity].
    Martínez Odriozola P; Ibarmia Lahuerta J; Gutiérrez Macías A; de la Villa FM
    Med Clin (Barc); 2007 Jun; 129(4):158-9. PubMed ID: 17663974
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
    Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al.
    Beiderbeck AB; Sakaguchi M
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity of thiazolidinediones.
    Isley WL
    Expert Opin Drug Saf; 2003 Nov; 2(6):581-6. PubMed ID: 14585066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.
    Ann Intern Med; 2002 Mar; 136(6):I65. PubMed ID: 11900516
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pioglitazone-induced acute severe hepatitis].
    Arotçarena R; Bigué JP; Etcharry F; Pariente A
    Gastroenterol Clin Biol; 2004; 28(6-7 Pt 1):610-1. PubMed ID: 15243398
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver toxicity and pioglitazone: data are missing.
    Amin P
    BMJ; 2004 Oct; 329(7471):918; author reply 918. PubMed ID: 15485987
    [No Abstract]   [Full Text] [Related]  

  • 11. "Did this drug cause my patient's hepatitis?" and related questions.
    Nierenberg DW
    Ann Intern Med; 2002 Mar; 136(6):480-3. PubMed ID: 11900502
    [No Abstract]   [Full Text] [Related]  

  • 12. Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.
    Ogimura E; Nakagawa T; Deguchi J; Sekine S; Ito K; Bando K
    Toxicol Sci; 2017 Aug; 158(2):347-355. PubMed ID: 28486596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rules and laws of drug hepatotoxicity.
    Kaplowitz N
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):231-3. PubMed ID: 16552791
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of drug induced liver injury related pioglitazone].
    Hisamochi A; Kumashiro R; Koga Y; Tanaka E; Ide T; Hino T; Murashima S; Ogata K; Kuwahara R; Koga H; Shishido S; Ueno T; Sata M; Eguchi T
    Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):333-6. PubMed ID: 12696176
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone.
    Rajagopalan R; Iyer S; Perez A
    Diabetes Obes Metab; 2005 Mar; 7(2):161-9. PubMed ID: 15715889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular injury in a patient receiving pioglitazone.
    Maeda K
    Ann Intern Med; 2001 Aug; 135(4):306. PubMed ID: 11511159
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.
    Lewis JH
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):221-9. PubMed ID: 16444771
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal hepatotoxicity associated with troglitazone.
    Vella A; de Groen PC; Dinneen SF
    Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776
    [No Abstract]   [Full Text] [Related]  

  • 20. Hy's law: predicting serious hepatotoxicity.
    Temple R
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):241-3. PubMed ID: 16552790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.